Holy Name Medical Center, Teaneck, NJ   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Teaneck NJ United States (1925)

Organization Overview

First Clinical Trial
2010
NCT01075399
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Holy Name Hospital | Holy Name Medical Center, Inc. | Holy Name Medical Center, Teaneck, NJ 07666

Active Ingredients

Drugs in Phase 4 Trials (3)

acetaminophen (tylenol) (1 trial)

peginterferon beta-1a (Plegridy) (1 trial)

prednisone (meticorten) (1 trial)

Drugs in Phase 3 Trials (1)

alteplase (Activase) (1 trial)

Drugs in Phase 2 Trials (2)

favipiravir (1 trial)

hx4 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Embolism (Phase 3)

Head and Neck Neoplasms (Phase 2)

Hypoxia (Phase 2)

Influenza, Human (Phase 2)

Liver Neoplasms (Phase 2)

Multiple Sclerosis (Phase 4)

Pulmonary Embolism (Phase 3)

Rectal Neoplasms (Phase 2)

Thromboembolism (Phase 3)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6